Tag: recurrence
ASCO: AstraZeneca’s Tagrisso, headed for big sales boost, cuts lung cancer...
In mid-April, at the recommendation of an independent data monitoring committee, AstraZeneca unblinded a phase 3 trial of Tagrisso two years early. Now, the...